Articulate Labs

Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment.

Company status:
* Working prototype
* Feasibility study conducted
* Four patents issued; two pending
* Independent market validation with likely prescribers
* Regulatory pathway established
* Reimbursement codes identified

This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.